Document Detail


Overview of treatment options for invasive fungal infections.
MedLine Citation:
PMID:  21366509     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The introduction of several new antifungals has significantly expanded both prophylaxis and treatment options for invasive fungal infections (IFIs). Relative to amphotericin B deoxycholate, lipid-based formulations of amphotericin B have significantly reduced the incidence of nephrotoxicity, but at a significant increase in drug acquisition cost. Newer, broad-spectrum triazoles (notably voriconazole and posaconazole) have added significantly to both the prevention and treatment of IFIs, most notably Aspergillus spp. (with voriconazole) and the treatment of some emerging fungal pathogens. Finally, a new class of parenteral antifungals, the echinocandins, is employed most frequently against invasive candidal infections. While the role of these newer agents continues to evolve, this review summarizes the activity, safety and clinical applications of agents most commonly employed in the treatment of IFIs.
Authors:
Melanie W Pound; Mary L Townsend; Vincent Dimondi; Dustin Wilson; Richard H Drew
Related Documents :
24639219 - The use of primary human cells (fibroblasts, monocytes, and others) to assess human cyt...
22550559 - Biology of human malaria plasmodia including plasmodium knowlesi.
24389569 - Severe oral manifestation of dengue viral infection: a rare clinical description.
22826479 - Detection of persistent west nile virus rna in experimentally and naturally infected av...
21449839 - Mosquito rnai is the major innate immune pathway controlling arbovirus infection and tr...
21543979 - Infection prevention and control in cystic fibrosis.
10546049 - The therapeutic use of isometamidium chloride against cryptobia salmositica in rainbow ...
1025649 - The problem of infections in acute leukemias. personal experience in diagnosis and trea...
17619249 - Influenza virus a (h5n1): a pandemic risk?
Publication Detail:
Type:  Journal Article; Review     Date:  2011-03-03
Journal Detail:
Title:  Medical mycology     Volume:  49     ISSN:  1460-2709     ISO Abbreviation:  Med. Mycol.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-18     Completed Date:  2011-10-31     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  9815835     Medline TA:  Med Mycol     Country:  England    
Other Details:
Languages:  eng     Pagination:  561-80     Citation Subset:  IM    
Copyright Information:
© 2011 ISHAM
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifungal Agents / adverse effects,  pharmacology,  therapeutic use*
Chemoprevention / methods
Humans
Mycoses / drug therapy*
Chemical
Reg. No./Substance:
0/Antifungal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Candida tropicalis biofilms: artificial urine, urinary catheters and flow model.
Next Document:  The effect of hyperglycemia on neonatal immune responses in-vitro.